{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:49:47Z","timestamp":1773967787149,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taipei City Hospital","award":["99001-62-019"],"award-info":[{"award-number":["99001-62-019"]}]},{"name":"Taipei City Hospital","award":["98001-62-007"],"award-info":[{"award-number":["98001-62-007"]}]},{"name":"Taipei City Hospital","award":["97002-62-045"],"award-info":[{"award-number":["97002-62-045"]}]},{"name":"Taipei Index Center","award":["TIPN-9904"],"award-info":[{"award-number":["TIPN-9904"]}]},{"name":"Taipei Medical University-Wan Fang Hospital","award":["99WF-EVA-01"],"award-info":[{"award-number":["99WF-EVA-01"]}]},{"name":"Taipei Medical University-Wan Fang Hospital","award":["100WF-EVA-09"],"award-info":[{"award-number":["100WF-EVA-09"]}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC97-2314-B-038-009-MY3"],"award-info":[{"award-number":["NSC97-2314-B-038-009-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC97-2314-B-532-001-MY3"],"award-info":[{"award-number":["NSC97-2314-B-532-001-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC99-2314-B-038-020-MY3"],"award-info":[{"award-number":["NSC99-2314-B-038-020-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Health, Executive Yuan","award":["DOH96-TD-D-113-033"],"award-info":[{"award-number":["DOH96-TD-D-113-033"]}]},{"DOI":"10.13039\/501100000272","name":"National Health Research Institute","doi-asserted-by":"crossref","award":["NHRI-EX99-9741PI"],"award-info":[{"award-number":["NHRI-EX99-9741PI"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.pnpbp.2011.07.014","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T03:46:38Z","timestamp":1312688798000},"page":"1927-1932","source":"Crossref","is-referenced-by-count":15,"title":["Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia"],"prefix":"10.1016","volume":"35","author":[{"given":"Po-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chiang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.07.014_bb0005","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","article-title":"Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients","volume":"65","author":"Arranz","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0020","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4088\/JCP.v68n1202","article-title":"Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia","volume":"68","author":"Bai","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0035","doi-asserted-by":"crossref","first-page":"E758","DOI":"10.1152\/ajpendo.90737.2008","article-title":"Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans","volume":"296","author":"Chavez","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pnpbp.2010.11.014","article-title":"Gender differences in the effects of peroxisome proliferator-activated receptor gamma2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder","volume":"35","author":"Chen","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0045","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.2004.02063.x","article-title":"Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans","volume":"61","author":"Choi","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/070674370404901106","article-title":"Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome","volume":"49","author":"Cohn","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-naive individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0070","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5551\/jat.1073","article-title":"Association between high molecular weight adiponectin levels and metabolic parameters","volume":"16","author":"Fujimatsu","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0080","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.yic.0000188215.84784.17","article-title":"High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia","volume":"21","author":"Hagg","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2006-1839","article-title":"Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects","volume":"92","author":"Haider","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","article-title":"A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder","volume":"106","author":"Hanssens","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc05-1801","article-title":"Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome","volume":"29","author":"Hara","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.metabol.2007.02.002","article-title":"13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration","volume":"56","author":"Heliovaara","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881105056647","article-title":"Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia","volume":"20","author":"Hosojima","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0447.2009.01401.x","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan","volume":"120","author":"Huang","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0120","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0026-0495(03)00313-5","article-title":"Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study","volume":"52","author":"Hulthe","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0125","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2337\/db06-0616","article-title":"Retinol-binding protein 4 in human obesity","volume":"55","author":"Janke","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.metabol.2003.12.008","article-title":"Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men","volume":"53","author":"Kazumi","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dmrr.222","article-title":"Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid","volume":"17","author":"Koistinen","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0140","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1381\/096089206778870058","article-title":"Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment\u2014a prospective study","volume":"16","author":"Kotidis","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0145","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwf145","article-title":"Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study","volume":"156","author":"Laaksonen","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0150","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","article-title":"Adiponectin multimeric complexes and the metabolic syndrome trait cluster","volume":"55","author":"Lara-Castro","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0165","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","article-title":"The metabolic syndrome and adipocytokines","volume":"580","author":"Matsuzawa","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1819.2007.01610.x","article-title":"Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia","volume":"61","author":"Murashita","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"issue":"Suppl 4","key":"10.1016\/j.pnpbp.2011.07.014_bb0185","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-4838(00)00150-3","article-title":"Plasma retinol binding protein: structure and function of the prototypic lipocalin","volume":"1482","author":"Newcomer","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0195","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure\u2013function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0200","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0205","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2006-2522","article-title":"Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor","volume":"92","author":"Promintzer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0210","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1210\/jc.2007-1219","article-title":"Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people","volume":"92","author":"Qi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","article-title":"Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia","volume":"26","author":"Richards","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0225","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2008.01.004","article-title":"Metabolic syndrome in first episode schizophrenia\u2014a randomized double-blind controlled, short-term prospective study","volume":"101","author":"Saddichha","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0235","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.metabol.2007.06.015","article-title":"High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men","volume":"56","author":"Seino","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.metabol.2008.10.008","article-title":"High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men","volume":"58","author":"Seino","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3349\/ymj.2010.51.3.375","article-title":"Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients","volume":"51","author":"Shim","year":"2010","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0255","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2010.04.001","article-title":"Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study","volume":"120","author":"Smith","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0265","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.chi.0000170552.15798.dd","article-title":"Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study","volume":"44","author":"Sporn","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0270","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMc061863","article-title":"Retinol-binding protein 4 and insulin resistance","volume":"355","author":"Takashima","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0275","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2006-1249","article-title":"Retinol binding protein-4 levels and clinical features of type 2 diabetes patients","volume":"92","author":"Takebayashi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-200401000-00007","article-title":"Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study","volume":"19","author":"Togo","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13813451003631421","article-title":"Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients","volume":"116","author":"Ulgen","year":"2010","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0290","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00125-007-0743-8","article-title":"Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease","volume":"50","author":"von Eynatten","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0295","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0300","article-title":"Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study","author":"Wampers","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0305","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00125-009-1386-8","article-title":"Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population","volume":"52","author":"Xu","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.07.014_bb0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/bjp.184.1.58","article-title":"Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia","volume":"184","author":"Zhang","year":"2004","journal-title":"Br J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:52:40Z","timestamp":1588809160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0278584611002442"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.014","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}